PepGen Net Income Applicable To Common Shares from 2010 to 2026
| PEPG Stock | USD 5.13 0.09 1.72% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -62.2 M | Current Value -59.1 M | Quarterly Volatility 29.9 M |
Check PepGen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PepGen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.8 M, Interest Expense of 4.1 M or Selling General Administrative of 25.7 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.1. PepGen financial statements analysis is a perfect complement when working with PepGen Valuation or Volatility modules.
PepGen | Net Income Applicable To Common Shares | Build AI portfolio with PepGen Stock |
The Net Income Applicable To Common Shares trend for PepGen offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether PepGen is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest PepGen's Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of PepGen over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. PepGen's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PepGen's overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
PepGen Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | (21,965,148) | |
| Coefficient Of Variation | (135.92) | |
| Mean Deviation | 26,362,309 | |
| Median | (1,346,000) | |
| Standard Deviation | 29,855,990 | |
| Sample Variance | 891.4T | |
| Range | 67.8M | |
| R-Value | (0.82) | |
| Mean Square Error | 305.4T | |
| R-Squared | 0.68 | |
| Significance | 0.000048 | |
| Slope | (4,871,259) | |
| Total Sum of Squares | 14262.1T |
PepGen Net Income Applicable To Common Shares History
About PepGen Financial Statements
PepGen stakeholders use historical fundamental indicators, such as PepGen's Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although PepGen investors may analyze each financial statement separately, they are all interrelated. For example, changes in PepGen's assets and liabilities are reflected in the revenues and expenses on PepGen's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in PepGen. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -62.2 M | -59.1 M |
Currently Active Assets on Macroaxis
When determining whether PepGen is a strong investment it is important to analyze PepGen's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PepGen's future performance. For an informed investment choice regarding PepGen Stock, refer to the following important reports:Check out the analysis of PepGen Correlation against competitors. For more detail on how to invest in PepGen Stock please use our How to Invest in PepGen guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Can Biotechnology industry sustain growth momentum? Does PepGen have expansion opportunities? Factors like these will boost the valuation of PepGen. Anticipated expansion of PepGen directly elevates investor willingness to pay premium valuations. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating PepGen demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
The market value of PepGen is measured differently than its book value, which is the value of PepGen that is recorded on the company's balance sheet. Investors also form their own opinion of PepGen's value that differs from its market value or its book value, called intrinsic value, which is PepGen's true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because PepGen's market value can be influenced by many factors that don't directly affect PepGen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between PepGen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PepGen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, PepGen's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.